Flywheel, a research data platform designed for the academic, clinical and life science communities, has announced its launch of Flywheel for Life Sciences. Flywheel for Life Sciences is an enterprise-scale research data management solution helping organizations realize their digital transformation strategy and improve R&D efficiency.
A digital transformation is underway in the life sciences and organizations are motivated to reduce R&D costs, improve operational efficiencies and shorten drug development timelines. To be successful, these organizations need to cost-effectively leverage high-quality data for the exploration of new solutions and reuse data collaboratively within data science & research teams. However, traditional R&D infrastructures are insufficient for large-scale data collection, complex data validation, automated quality controls, and scaling processing (and AI) pipelines.
Flywheel offers a scalable research-first platform that can capture imaging and related data from multiple siloed sources, including CROs and historical clinical trials. Flywheel integrates with existing data pipelines and software tools to ingest multi-modal data, and then consolidate, curate, validate, and disseminate that data to analytics and machine learning platforms. With the provenance to support regulatory approvals and scientific reproducibility, Flywheel supports secure collaboration to solve problems with multi-disciplinary teams internal and external to organizations.
Now with Flywheel for Life Sciences, the solution incorporates new enterprise scaling features that help support the needs of large, global life sciences organizations and their massive volumes of data from diverse sources all over the world. These features include high speed bulk loading, horizontal and vertical scaling, version control deployments, and the provenance to support audit readiness.
Flywheel leverages the full power of modern cloud computing to deliver the performance and reliability needed in the life sciences. Flywheel offers enterprise deployments on major providers such as Amazon Web Services, Google Cloud, and Microsoft Azure. Flywheel for Life Sciences is delivered as a fully managed service allowing digital, operations, data, and clinical teams to focus on research and results rather than IT.
With expertise in medical imaging and computer science, the Flywheel team partners with life sciences organizations to tailor and deliver a system that meets enterprise requirements and critical schedules.
"We are excited to launch our Life Sciences solution to streamline and leverage imaging data assets and machine learning workflows, helping organizations increase R&D efficiency and accelerate drug discovery," said Travis Richardson, Chief Product Officer of Flywheel.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
POETYK PsA-2 Trial Shows Efficacy of Sotyktu as an Oral Therapy for Psoriatic Arthritis
March 11th 2025Sotyktu (deucravacitinib) demonstrated significant efficacy in improving psoriatic arthritis symptoms compared to placebo in the Phase III POETYK PsA-2 trial, with a well-tolerated safety profile.